This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2019-2020.
Location History:
- Uttar Pradesh, IN (2019)
- Lucknow, IN (2020)
Company Filing History:
Years Active: 2019-2020
Title: Dharmendra Choudhary: Innovator in Pharmaceutical Composition
Introduction
Dharmendra Choudhary is a notable inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of bone-related disorders. With a total of 2 patents to his name, his work is paving the way for advancements in medical treatments.
Latest Patents
Choudhary's latest patents include a pharmaceutical composition for the treatment of the diminution of bone tissue. This method utilizes a composition comprising compounds such as Withaferin A (WFA), Withanolide A, and Withanone. The composition has shown enhanced bioavailability of WFA in rodents compared to plain WFA, promoting bone marrow cell differentiation and increasing the percent of bone volume to tissue volume (BV/TV %) by three folds compared to free WFA. His second patent focuses on a formulation for the prevention and treatment of bone-related disorders. This invention relates to pharmaceutical formulations that provide extracts, fractions, and pure compounds isolated from natural sources, aimed at treating various medical indications, including conditions associated with osteoporosis and osteoarthritis.
Career Highlights
Choudhary is affiliated with the Council of Scientific and Industrial Research, where he continues to innovate and contribute to the field of pharmaceutical sciences. His research is crucial in addressing osteo-health-related disorders, which affect many individuals globally.
Collaborations
Choudhary has collaborated with notable coworkers such as Sulekha Adhikary and Prabhat Ranjan Mishra, enhancing the scope and impact of his research.
Conclusion
Dharmendra Choudhary's work in pharmaceutical compositions is instrumental in advancing treatments for bone-related disorders. His innovative approach and dedication to research are commendable and contribute significantly to the medical field.